Worldwide risk factors in leishmaniasis
|
摘要
Recently, Vector-borne parasitic diseases such as leishmaniasis have been emerged or reemerged in many geographical areas and resulted in global health and economic concerns that involve humans, domestic animals and wild life. The ecology and epidemiology of leishmaniasis are affected by the between host, reservoir and vector(human, animal and sandfly) and the environment. Important drivers for the emergence and spread of leishmaniasis include environmental factors such as alterations in temperature and water storage, irrigation habits, deforestation, climate changes, immunosuppression by HIV or organ transplant, development of drug resistance, increase traveling to endemic regions and dog importation. War, poor socio-economic status and low level household are also major contributors to the spread of this disease. Health education via the public media and training should be implemented by international organizations and governmental agencies in collaboration with research institutions. During transmission season, fully protection can be mentioned by using bednets and insecticides and reservoirs' control in the planning. Based on the findings of the recent studies and high prevalence of leishmaniasis, it is concluded that serious public health monitoring should be considered.
Recently, Vector-borne parasitic diseases such as leishmaniasis have been emerged or reemerged in many geographical areas and resulted in global health and economic concerns that involve humans, domestic animals and wild life. The ecology and epidemiology of leishmaniasis are affected by the between host, reservoir and vector(human, animal and sandfly) and the environment. Important drivers for the emergence and spread of leishmaniasis include environmental factors such as alterations in temperature and water storage, irrigation habits, deforestation, climate changes, immunosuppression by HIV or organ transplant, development of drug resistance, increase traveling to endemic regions and dog importation. War, poor socio-economic status and low level household are also major contributors to the spread of this disease. Health education via the public media and training should be implemented by international organizations and governmental agencies in collaboration with research institutions. During transmission season, fully protection can be mentioned by using bednets and insecticides and reservoirs' control in the planning. Based on the findings of the recent studies and high prevalence of leishmaniasis, it is concluded that serious public health monitoring should be considered.
Recently, Vector-borne parasitic diseases such as leishmaniasis have been emerged or reemerged in many geographical areas and resulted in global health and economic concerns that involve humans, domestic animals and wild life. The ecology and epidemiology of leishmaniasis are affected by the between host, reservoir and vector(human, animal and sandfly) and the environment. Important drivers for the emergence and spread of leishmaniasis include environmental factors such as alterations in temperature and water storage, irrigation habits, deforestation, climate changes, immunosuppression by HIV or organ transplant, development of drug resistance, increase traveling to endemic regions and dog importation. War, poor socio-economic status and low level household are also major contributors to the spread of this disease. Health education via the public media and training should be implemented by international organizations and governmental agencies in collaboration with research institutions. During transmission season, fully protection can be mentioned by using bednets and insecticides and reservoirs' control in the planning. Based on the findings of the recent studies and high prevalence of leishmaniasis, it is concluded that serious public health monitoring should be considered.
引文
[1]Oryan A,Mehrabani D,Owji SM,Motazedian MH,Hatam G H Asgari Q.Morphologic Changes due to Cutaneous Leishmaniosis in BALB/c Mice Experimentally Infected with Leishmania major.J Appl Anim Res2008;34:87-92.
[2]Shirian S,Oryan A,Hatam GR,Daneshbod Y.Three Leishmania/L.species--L.infantum,L.major,L.tropica--as causative agents of mucosal leishmaniasis in Iran.Pathog Glob Health 2013;107:267-272.
[3]Herwaldt BL.Leishmaniasis.Lancet 1999;354:1191-1199.
[4]Oryan A,Shirian S,Tabandeh MR,Hatam GR,Randau G,Daneshbod Y.Genetic diversity of Leishmania major strains isolated from different clinical forms of cutaneous leishmaniasis in southern Iran based on minicircle kD NA.Infect Genet Evol 2013;19:226-231.
[5]Shirian S,Oryan A,Hatam GR,Panahi S,Daneshbod Y.Comparison of conventional,molecular,and immunohistochemical methods in diagnosis of typical and atypical cutaneous leishmaniasis.Arch Pathol Lab Med2014;138:235-240.
[6]WHO Expert Committee on the Control of the Leishmaniases.Control of the leishmaniases:report of a WHO expert committee.World Health Organization.1990;World Health Organization technical report series;no.793.
[7]Davies CR,Kaye P,Croft SL,Sundar S.Leishmaniasis:new approaches to disease control.BMJ 2003;326:377-382.
[8]Alidadi S,Oryan A.Cutaneous Leishmaniasis and the Strategies for Its Prevention and Control.Trop Med Surg 2014;2:e114.doi:10.4172/2329-9088.1000e114.
[9]Desjeux P.Leishmaniasis:current situation and new perspectives.Comp Immunol Microbiol Infect Dis 2004;27:305-318.
[10]Oryan A,Mehrabani D,Owji SM,Motazedian MH,Asgari Q.Histopathologic and electron microscopic characterization of cutaneous leishmaniasis in Tatera indica and Gerbillus spp.infected with Leishmania major.Comp Clin Pathol 2007;16:275-279.
[11]WHO.Urbanization:an increasing risk factor for leishmaniasis(WER).Geneva.World Health Organization.2002;44:P,365.
[12]Votypka J,Kasap OE,Volf P,Kodym P,Alten B.Risk factors for cutaneous leishmaniasis in Cukurova region,Turkey.Trans R Soc Trop Med Hyg 2012;106:186-190.
[13]Reveiz L,Maia-Elkhoury AN,Nicholls RS,Romero GA,Yadon ZE.Interventions for American cutaneous and mucocutaneous leishmaniasis:a systematic review update.PLoS One 2013;8:e61843.
[14]Assimina Z,Charilaos K,Fotoula B.Leishmaniasis:an overlooked public health concern.Health Sci J 2008;2:196-205.
[15]Bashaye S,Nombela N,Argaw D,Mulugeta A,Herrero M,Nieto J,et al.Risk factors for visceral leishmaniasis in a new epidemic site in Amhara region,Ethiopia.Am J Trop Med Hyg 2009;81:34-39.
[16]Desta A,Shiferaw S,Kassa A,Shimelis T,Dires S.Module on leishmaniasis for the Ethiopian health center team.Ethiopia:Debub University;2005.
[17]Belen A,Alten B.Variation in life table characteristics among populations of Phlebotomus papatasi at different altitudes.J Vector Ecol2005;31:35-44.
[18]Colacicco-Mayhugh MG,Masuoka PM,Grieco JP.Ecological niche model of Phlebotomus alexandri and P.papatasi(Diptera:Psychodidae)in the Middle East.Int J Health Geogr 2010;9:2.
[19]Cruz I,Morales MA,Noguer I,Rodriquez A,Alvar J.Leishmania in discarded syringes from intravenous drug users(IVDUs).Lancet 2002;359:1124-1125.
[20]Ivanovski N,Popov Z,Cakalaroski K,Masin J,Spasovski G,Zafi rovska K.Living-unrelated(paid)renal transplantation:ten years later.Transplant Proc 2005;37:563-564.
[21]Patel R,Paya CV.Infections in solid-organ transplant recipients.Clin Microbiol Rev 1997;10:86-124.
[22]Molina R,Gradoni L,Alvar J.HIV and the transmission of Leishmania.Ann Trop Med Parasitol 2002;97(suppl 1):S29-S45.
[23]Jopikii L,Salmela K,Saha H,Kyr?nsepp?H,Eklund B,Evans D,et al.Leishmaniasis diagnosed from bronchoalveolar lavage.Scand J Infect Dis1992;24:677-681.
[24]Halkic N,Ksontini R,Scholl B,Blanc C,Kovacsovics T,Meylan P,et al.Recurrent cytomegalovirus disease,visceral leishmaniosis,and legionella pneumonia after liver transplantation:a case report.Can J Anaesth 2004;51:84-87.
[25]Llorente S,Gimeno L,Navarro MJ,Moreno S,Rodriguez-Girones M.Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials.Transplantation 2000;70:800-801.
[26]Sirvent-von Bueltzingsloewen A,Marty P,Rosenthal E.Visceral leishmaniasis a new opportunistic infection in hematopoietic stem-celltransplanted patients.Bone Marrow Transplant 2004;33:667-668.
[27]Hussein MM,Mooij JM,Roujouleh HM,Hamour AO,Felemban H.Non-typhoid salmonella septicemia and visceral leishmaniosis in a renal transplant patient.Transplantation 2001;71:479-481.
[28]Sabbatini M,Pisani A,Ragosta A,Gallo R,Borrelli F,Cianciaruso B.Visceral leishmaniasis in renal transplant recipients:is it a challenge to the nephrologist?Transplantation 2002;73:299-301.
[29]Maggi P,Gaudiano V,Valente M,Latorraca A,Cavaliere RL,Marroni M,et al.Leishmaniasis in patients with chronic renal failure:a diagnostic and therapeutic challenge for the clinician.J Nephrol 2004;17:296-301.
[30]Boelaert M,Criel B,Leeuwenburg J,Van Damme W,Le Ray D,Van der Stuyft P.Visceral leishmaniasis control:a public health perspective.Trans R Soc Trop Med Hyg 2000;94:465-471.
[31]Alvar J,Molina R,San Andrés M,Tesouro M,Nieto J,Vitutia M,et al.Canine leishmaniasis:clinical,parasitological and entomological followup after chemotherapy.Ann Trop Med Parasitol 1994;88:371-378.
[32]Gavgani AS,Hodjati MH,Mohite H,Davies CR.Effect of insecticideimpregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children:a matched-cluster randomized trial.Lancet 2002;360:374-379.
[33]Guerin PJ,Olliaro P,Sundar S,Boelaert M,Croft SL,Desjeux P,et al.Visceral leishmaniasis:current status of control,diagnosis,and treatment,and a proposed research and development agenda.Lancet Infect Dis 2002;2:494-501.
[34]Ameen M.Cutaneous leishmaniasis:therapeutic strategies and future directions.Expert Opin Pharmacother 2007;8:2689-2699.
[35]Collin S,Davidson R,Ritmeijer K,Keus K,Melaku Y,Kipngetich S,Davies C.Conflict and kala-azar:determinants of adverse outcomes of kala-azar among patients in southern Sudan.Clin Infect Dis 2004;38:612-619.
[36]Croft SL,Sundar S,Fairlamb AH.Drug resistance in leishmaniasis.Clin Microbiol Rev 2006;19:111-126.
[37]Sundar S,More DK,Singh MK,Singh VP,Sharma S,Makharia A,et al.Failure of pentavalent antimony in visceral leishmaniasis in India:report from the center of the Indian epidemic.Clin Infect Dis 2000;31:1104-1107.
[38]Gradoni L,Gramiccia M,Scalone A.Visceral leishmaniasis treatment,Italy.Emerg Infect Dis 2003;9:1617-1620.
[39]Bern C,Adler-Moore J,Berenguer J,Boelaert M,den Boer M,Davidson RN,et al.Liposomal amphotericin B for the treatment of visceral leishmaniasis.Clin Infect Dis 2006;43:917-924.
[40]Pérez-Victoria FJ,Sánchez-Ca?ete MP,Seifert K,Croft SL,Sundar S,Castanys S,et al.Mechanisms of experimental resistance of Leishmania to miltefosine:implications for clinical use.Drug Resist Update 2006;9:26-39.
[41]Thakur CP.Socio-economics of visceral leishmaniasis in Bihar(India).Trans R Soc Trop Med Hyg 2000;94:156-157.
[42]Bryceson A.A policy for leishmaniasis with respect to the prevention and control of drug resistance.Trop Med Int Health 2001;6:928-934.
[43]El Hajj L,Thellier M,Carriere J,Bricaire F,Danis M,Caumes E.Localized cutaneous leishmaniasis imported into Paris:a review of 39cases.Int J Dermatol 2004;43:120-125.
[44]Rosbotham JL,Corbett EL,Grant HR,Hay RJ,Bryceson AD.Imported mucocutaneous leishmaniasis.Clin Exp Dermatol 1996;21:288-290.
[45]Galioto P,Fornaro V.A case of mucocutaneous leishmaniasis.Ear Nose Throat J 2002;81:46-48.
[46]Alcais A,Abel L,David C,Torrez ME,Flandre P,Dedet JP.Risk factors for onset of cutaneous and mucocutaneous leishmaniasis in Bolivia.Am J Trop Med Hyg 1997;57:79-84.
[47]Harms G,Schonian G,Feldmeier H.Leishmaniasis in Germany.Emerg infect Dis 2003;9:872-875.
[48]Naucke TJ,Schmitt C.Is leishmaniasis becoming endemic in Germany?Int J Med Microbiol 2004;37:179-181.
[49]Duprey ZH,Steurer FJ,Rooney JA,Kirchhoff LV,Jackson JE,Rowton ED,et al.Canine visceral leishmaniasis,United States and Canada,2000-2003.Emerg infect Dis 2006;12:440-446.
[50]Desjeux P.The increase in risk factors for leishmaniasis worldwide.Trans R Soc Trop Med Hyg 2001;95:239-243.
[51]Meinecke CK,Schottelius J,Oskam L,Fleischer B.Congenital transmission of visceral leishmaniasis(kala azar)from an asymptomatic mother to her child.Pediatrics 1999;104:65.
[52]Trotz-Williams LA,Trees AJ.Systematic review of the distribution of the major vector-borne parasitic infections in dogs and cats in Europe.Vet Rec 2003;152:97-105.
[53]Mettler M,Grimm F,Naucke TJ,Maasjost C,Deplazes P.Canine leishmaniosis in Central Europe:retrospective survey and serological study of imported and travelling dogs.Berl Münch tier?rztl Wochenschr2005;118:37-44.
[54]Dantas-Torres F,Solano-Gallego L,Baneth G,Ribeiro VM,de PaivaCavalcanti M,Otranto D.Canine leishmaniosis in the Old and New Worlds:unveiled similarities and differences.Trends Parasitol 2012;28:531-538.
[55]Maroli M,Rossi L,Baldelli R,Capelli G,Ferroglio E,Genchi C,et al.The northward spread of leishmaniasis in Italy:evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors.Trop Med Int Health 2008;13:256-264.
[56]Otranto D,Paradies P,de Caprariis D,Stanneck D,Testini G,Grimm F,et al.Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic.Clin Vaccine Immunol2009;16:337-343.
[57]Petersen CA,Barr SC.Canine leishmaniasis in North America:emerging or newly recognized?Vet Clin North Am Small Anim 2009;39:1065-1074.
[58]Naucke TJ,Lorentz S.First report of venereal and vertical transmission of canine leishmaniosis from naturally infected dogs in Germany.Parasit Vectors 2012;5:67.
[59]World Health Organization.Leishmania/HIV co-infection,south-western Europe,1990–1998.WER.1999;74:365-375.
[60]Marty P,Izri A,Ozon C,Haas P,Rosenthal E,Del Giudice P et al.A century of leishmaniasis in Alpes-Maritimes,France.Ann Trop Med Parasitol 2007;101:563-574.
[61]Alvar J,Aparicio P,Aseffa A,Den Boer M,Ca?avate C,Dedet JP,et al.The relationship between leishmaniasis and AIDS:the second 10 years.Clin Microbiol Rev 2008;21:334-359.
[62]Cascio A,Gradoni L,Scarlata F,Gramiccia M,Giordano S,Russo R,et al.Epidemiological surveillance of visceral leishmaniasis in Sicily.Am J Trop Med Hyg 1997;57:75-78.
[63]Mannocci A,La Torre G,Chiaradia G,De Waure C,Mainelli MT,Cernigliaro A,et al.Epidemiology and direct medical costs of human leishmaniasis in Italy.J Prev Med Hyg 2007;48:27-36.
[64]Desjeux P,Alvar J.Leishmania/HIV co-infections:epidemiology in Europe.Ann trop Med Parasitol 2003;97:S3-S15.
[65]Gabutti G,Balestra G,Fkego G,Crovari P.Visceral leishmaniasis in Liguria,Italy.Lancet 1998;351:1136.
[66]Pagliano P,Rossi M,Rescigno C,Altieri S,Coppola MG,Gramiccia M,et al.Mediterranean visceral leishmaniasis in HIV negative adults:a retrospective analysis of 64 consecutive cases(1995-2001).J Antimicrob Chemother 2003;52:264-268.
[67]Russo R,Laguna F,López-Vélez R,Medrano FJ,Rosenthal E,Cacopardo B,et al.Visceral leishmaniasis in those infected with HIV:clinical aspects and other opportunistic infections.Ann Trop Med Parasitol 2003;97:99-105.
[68]Noyes HA,Reyburn H,Bailey W,Smith D.A nested PCR based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan.J Clin Microbiol1998;36:2877-2881.
[69]Malik ANJ,John L,Bryceson ADM,Lockwood DNJ.Changing Pattern of Visceral Leishmaniasis,United Kingdom,1985-2004.Emerg Infect Dis2006;12:1257-1259.
[70]Garrote JI,Gutiérrez MP,Izquierdo RL,Due?as MA,Zarzosa P,Ca?avate C,et al.Seroepidemiologic study of Leishmania infantum infection in Castilla-Leon,Spain.Am J Trop Med Hyg 2004;71:403-6.
[71]Riera C,Fisa R,Udina M,Gállego M,Portus M.Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area(Eivissa,Balearic islands,Spain)by different diagnostic methods.Trans R Soc Trop Med Hyg 2004;98:102-110.
[72]Bates PA.Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies.Int J Parasitol 2007;37:1097-1106.
[73]Franke CR,Staubach C,Ziller M,Schluter H.Trends in the temporal and spatial distribution of visceral and cutaneous leishmaniasis in the state of Bahia Brazil from 1985 to 1999.Trans R Soc Trop Med Hyg 2002;96:236-241.
[74]Ready PD.Leishmaniasis emergence and climate change.In:S de la Roque,editor.Climate change:the impact on the epidemiology and control of animal diseases.Rev Sci Tech Off Int Epiz 2008;27:399-412.
[75]Reithinger R,Canales Espinoza J,Llanos-Cuentas A,Davies CR.Domestic dog ownership:a risk factor for human infection with Leishmania(Viannia)species.Trans R Soc Trop Med Hyg 2003;97:141-145.
[76]Negera E,Gadisa E,Yamuah L,Engers H,Hussein J,Kuru T,et al.Outbreak of cutaneous leishmaniasis in Silti woreda,Ethiopia:risk factor assessment and causative agent identification.Trans R Soc Trop Med Hyg2008;102:883-890.
[77]Pedrosa Fde A,Ximenes RA.Sociodemographic and environmental risk factors for American cutaneous leishmaniasis(ACL)in the State of Alagoas,Brazil.Am J Trop Med Hyg 2009;81:195-201.
[78]Reithinger R,Mohsen M,Leslie T.Risk Factors for Anthroponotic Cutaneous Leishmaniasis at the Household Level in Kabul,Afghanistan.PLoS Negl Trop Dis 2010;4:e639.
[79]Killick-Kendrick R.The biology and control of phlebotomine sand flies.Clin Dermatol 1999;17:279-289.
[80]Kirby MJ,Ameh D,Bottomley C,Green C,Jawara M,Milligan PJ,et al.Effect of two different house screening interventions on exposure to malaria vectors and on anaemia in children in The Gambia:a randomised controlled trial.Lancet 2009;374:998-1009.
[81]Boelaert M,Meheus F,Sanchez A,Singh SP,Vanlerberghe V,Picado A,et al.The poorest of the poor:a poverty appraisal of households affected by visceral leishmaniasis in Bihar,India.Trop Med Int Health 2009;14:639-644.
[82]Bern C,Courtenay O,Alvar J.Of cattle,sandflies and men:a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination.PLoS Negl Trop Dis 2010;4:e599.
[83]Hasker E,Singh SP,Malaviya P,Picado A,Gidwani K,Singh RP,et al.Visceral leishmaniasis in rural bihar,India.Emerg Infect Dis 2012;18:1662-1664.
[84]Pascual Mart?′nez F,Picado A,Roddy P,Palma P.Low castes have poor access to visceral leishmaniasis treatment in Bihar,India.Trop Med Int Health 2012;17:666-673.
[85]Stauch A,Sarkar RR,Picado A,Ostyn B,Sundar S,Rijal S,et al.Visceral leishmaniasis in the Indian subcontinent:modelling epidemiology and control.PLoS Negl Trop Dis 2011;5:e1405.
[86]Barnett PG,Singh SP,Bern C,Hightower AW,Sundar S.Virgin soil:the spread of visceral leishmaniasis into Uttar Pradesh,India.Am J Trop Med Hyg 2005;73:720-725.
[87]Picado A,Ostyn B,Singh SP,Uranw S,Hasker E,Rijal S,et al.Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal.PLoS One 2014;9:e87641.
[88]Saha S,Ramachandran R,Hutin YJF,Gupte MD.Visceral leishmaniasis is preventable in a highly endemic village in West Bengal,India.Trans R Soc Trop Med Hyg 2009;103:737-742.
[89]Yazdanpanah HA,Rostamianpur M.Analysis of spatial distribution of leishmaniasis and its relationship with climatic parameters(Case study:Ilam Province).Bull Env Pharmacol Life Sci 2013;2:80-86.
[90]Mozafari Y,Bakhshizade Koloche F.The Review Relationship between vegetation and the prevalence of skin disease,cutaneous leishmaniasis using GIS in Yazd–ardakan.J Geo Environ Plan 2011;4:186.
[91]Dawit G,Shishay K.Epidemiology,Public Health Impact and Control Methods of the Most Neglected Parasite Diseases in Ethiopia:A Review.World J Med Scien 2014;10:94-102.
[92]Patz JA,Graczyk TK,Geller N,Vittor AY.Effects of environmental change on emerging parasitic diseases.Int J Parasitol 2000;30:1395-1405.
[93]Malone JB,Yilma JM,McC arroll JC,Erko B,Mukaratirwa S,Zhou X.Satellite climatology and the environmental risk of Schistosoma mansoni in Ethiopia and east Africa.Acta Trop 2001;79:59-72.
[94]Brownstein JS,Holford TR,Fish D.A climate-based model predicts the spatial distribution of the lyme disease vector Ixodes scapularis in the United States.Environ Health Perspect 2003;111:1152-1157.
[95]Gebre-Michael T,Malone JB,Balkew M,Ali A,Berhe N,Hailu A,Herzi AA.Mapping the potential distribution of Phlebotomus martini and P.orientalis(Diptera:Psychodidae),vectors of kala-azar in East Africa by use of geographic information systems.Acta Trop 2004;90:73-86.
[96]Brownstein JS,Skelly DK,Holford TR,Fish D.Forest fragmentation predicts local scale heterogeneity of Lyme disease risk.Oecologia 2005;146:469-475.
[97]Silue KD,Raso G,Yapi A,Vounatsou P,Tanner M,N’goran EK,et al.Spatially-explicit risk profiling of Plasmodium falciparum infections at a small scale:a geostatistical modeling approach.Malar J 2008;7:111.
[98]King RJ,Campbell-Lendrum DH,Davies CR.Predicting geographic variation in cutaneous leishmaniasis,Colombia.Emerg Infect Dis 2004;10:598-607.
[99]Feliciangeli MD,Delgado O,Suarez B,Bravo A.Leishmania aand sand flies:proximity to woodland as a risk factor for infection in a rural focus of visceral leishmaniasis in west central Venezuela.Trop Med Int Health2006;11:1785-1791.
[100]Walsh JF,Molyneaux DH,Birley MH.Deforestation:effects on vectorborne disease.Parasitology 1993;106:55-75.
[101]Davies CR,Reithinger R,Campbell-Lendrum D,Feliciangeli D,Borges R,Rodriguez N.The epidemiology and control of leishmaniasis in Andean countries.Cad Saude Publica 2000;16:925-950.
[102]Elnaiem DE,Schorscher J,Bendall A,Obsomer V,Osman ME,Mekkawi AM,et al.Risk mapping of visceral leishmaniasis:the role of local variation in rainfall and altitude on the presence and incidence of kala-azar in eastern Sudan.Am J Trop Med Hyg 2003;6:10-17.
[103]Chaves LF,Pascual M.Climate cycles and forecasts of cutaneous leishmaniasis,a nonstationary vector-borne disease.PLoS Med 2006;3:e295.
[104]Valderrama-Ardila C,Alexander N,Ferro C,Cadena H,Marín D,Holford TR,et al.Environmental Risk Factors for the Incidence of American Cutaneous Leishmaniasis in a Sub-Andean Zone of Colombia(Chaparral,Tolima).Am J Trop Med Hyg 2010;82:243-250.
[105]Kassiri H,Shemshad Kh,Lotfi M,Shemshad M.Relationship Trend Analysis of Cutaneous Leishmaniasis Prevalence and Climatological Variables in Shush County,South-West of Iran(2003-2007).Acad J Entomol 2013;6:79-84.
[106]Moosa-Kazemi SH,Yaghoobi-Ershadir MR,Akhavan AA,Abdoli H,Zahraei-Ramazani AR,Jafari R,et al.Deltamethrin-Impregnated Bed Nets and Curtains in an Anthroponotic Cutaneous leishmaniasis Control Program in Northeastern Iran.Ann Saudi Med 2007;27:6-12.
[107]Bailey MS,Diana NJ.Cutaneous Leishmaniasis.Clinics in Dermatology2007;25:203-211.
[108]Rastogi V,Nirwan PS.Cutaneous Leishmaniasis:an Emerging Infection in a Non-Endemic Area and a Brief Update.Indian J Med Microbiol2007;25:272-275.
[109]Stewart CC,Brieger WR.Community Views on Cutaneous Leishmaniasis in Istalif,Afghanistan:Implications for Treatment and Prevention.Int Q Community Health Educ 2009;29:123-142.
[110]Hotez PJ,Remme JH,Buss P,Alleyne G,Morel C,Breman JG.Combating tropical infectious diseases:report of the Disease Control Priorities in Developing Countries Project.Clin Infect Dis 2004;38:871-878.
[111]Ahluwalia IB,Bern C,Costa C,Akter T,Chowdhury R,Ali M,et al.Visceral leishmaniasis:consequences of a neglected disease in a Bangladeshi community.Am J Trop Med Hyg 2003;69:624-628.
[112]Alvar J,Yactayo S,Bern C.Leishmaniasis and poverty.Trends Parasitol2006;22:552-557.
[113]Rijal S,Koirala S,Van der Stuyft P,Boelaert M.The economic burden of visceral leishmaniasis for households in Nepal.Trans R Soc Trop Med Hyg 2006;100:838-841.
[114]Gafurov IM.Experience in controlling and preventing zoonotic cutaneous leishmaniasis in Uzbekistan.Med Parazitol(Mosk)1999;1:58-59.
[115]Dantas-Torres F,Brandao-Filho SP.Visceral leishmaniasis in Brazil:revisiting paradigms of epidemiology and control.Rev Inst Med Trop Sao Paulo 2006;48:151-156.
[116]Palatnik-de-Sousa CB.Vaccines for leishmaniasis in the fore coming 25years.Vaccine 2008;26:1709-1724.
[117]World Health Organization(WHO).Leishmaniasis:background information.A brief history of the disease.[Online]Available from:www.who.int/leishmaniasis/en/[accssed on 10 May,2016]
[118]Alvar J,Ca?avate C,Gutiérrez-Solar B,Jiménez M,Laguna F,LópezVélez R,et al.Leishmania and human immunodeficiency virus coinfection:the first 10 years.Clin Microbiol Rev 1997;10:298-319.
[2]Shirian S,Oryan A,Hatam GR,Daneshbod Y.Three Leishmania/L.species--L.infantum,L.major,L.tropica--as causative agents of mucosal leishmaniasis in Iran.Pathog Glob Health 2013;107:267-272.
[3]Herwaldt BL.Leishmaniasis.Lancet 1999;354:1191-1199.
[4]Oryan A,Shirian S,Tabandeh MR,Hatam GR,Randau G,Daneshbod Y.Genetic diversity of Leishmania major strains isolated from different clinical forms of cutaneous leishmaniasis in southern Iran based on minicircle kD NA.Infect Genet Evol 2013;19:226-231.
[5]Shirian S,Oryan A,Hatam GR,Panahi S,Daneshbod Y.Comparison of conventional,molecular,and immunohistochemical methods in diagnosis of typical and atypical cutaneous leishmaniasis.Arch Pathol Lab Med2014;138:235-240.
[6]WHO Expert Committee on the Control of the Leishmaniases.Control of the leishmaniases:report of a WHO expert committee.World Health Organization.1990;World Health Organization technical report series;no.793.
[7]Davies CR,Kaye P,Croft SL,Sundar S.Leishmaniasis:new approaches to disease control.BMJ 2003;326:377-382.
[8]Alidadi S,Oryan A.Cutaneous Leishmaniasis and the Strategies for Its Prevention and Control.Trop Med Surg 2014;2:e114.doi:10.4172/2329-9088.1000e114.
[9]Desjeux P.Leishmaniasis:current situation and new perspectives.Comp Immunol Microbiol Infect Dis 2004;27:305-318.
[10]Oryan A,Mehrabani D,Owji SM,Motazedian MH,Asgari Q.Histopathologic and electron microscopic characterization of cutaneous leishmaniasis in Tatera indica and Gerbillus spp.infected with Leishmania major.Comp Clin Pathol 2007;16:275-279.
[11]WHO.Urbanization:an increasing risk factor for leishmaniasis(WER).Geneva.World Health Organization.2002;44:P,365.
[12]Votypka J,Kasap OE,Volf P,Kodym P,Alten B.Risk factors for cutaneous leishmaniasis in Cukurova region,Turkey.Trans R Soc Trop Med Hyg 2012;106:186-190.
[13]Reveiz L,Maia-Elkhoury AN,Nicholls RS,Romero GA,Yadon ZE.Interventions for American cutaneous and mucocutaneous leishmaniasis:a systematic review update.PLoS One 2013;8:e61843.
[14]Assimina Z,Charilaos K,Fotoula B.Leishmaniasis:an overlooked public health concern.Health Sci J 2008;2:196-205.
[15]Bashaye S,Nombela N,Argaw D,Mulugeta A,Herrero M,Nieto J,et al.Risk factors for visceral leishmaniasis in a new epidemic site in Amhara region,Ethiopia.Am J Trop Med Hyg 2009;81:34-39.
[16]Desta A,Shiferaw S,Kassa A,Shimelis T,Dires S.Module on leishmaniasis for the Ethiopian health center team.Ethiopia:Debub University;2005.
[17]Belen A,Alten B.Variation in life table characteristics among populations of Phlebotomus papatasi at different altitudes.J Vector Ecol2005;31:35-44.
[18]Colacicco-Mayhugh MG,Masuoka PM,Grieco JP.Ecological niche model of Phlebotomus alexandri and P.papatasi(Diptera:Psychodidae)in the Middle East.Int J Health Geogr 2010;9:2.
[19]Cruz I,Morales MA,Noguer I,Rodriquez A,Alvar J.Leishmania in discarded syringes from intravenous drug users(IVDUs).Lancet 2002;359:1124-1125.
[20]Ivanovski N,Popov Z,Cakalaroski K,Masin J,Spasovski G,Zafi rovska K.Living-unrelated(paid)renal transplantation:ten years later.Transplant Proc 2005;37:563-564.
[21]Patel R,Paya CV.Infections in solid-organ transplant recipients.Clin Microbiol Rev 1997;10:86-124.
[22]Molina R,Gradoni L,Alvar J.HIV and the transmission of Leishmania.Ann Trop Med Parasitol 2002;97(suppl 1):S29-S45.
[23]Jopikii L,Salmela K,Saha H,Kyr?nsepp?H,Eklund B,Evans D,et al.Leishmaniasis diagnosed from bronchoalveolar lavage.Scand J Infect Dis1992;24:677-681.
[24]Halkic N,Ksontini R,Scholl B,Blanc C,Kovacsovics T,Meylan P,et al.Recurrent cytomegalovirus disease,visceral leishmaniosis,and legionella pneumonia after liver transplantation:a case report.Can J Anaesth 2004;51:84-87.
[25]Llorente S,Gimeno L,Navarro MJ,Moreno S,Rodriguez-Girones M.Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials.Transplantation 2000;70:800-801.
[26]Sirvent-von Bueltzingsloewen A,Marty P,Rosenthal E.Visceral leishmaniasis a new opportunistic infection in hematopoietic stem-celltransplanted patients.Bone Marrow Transplant 2004;33:667-668.
[27]Hussein MM,Mooij JM,Roujouleh HM,Hamour AO,Felemban H.Non-typhoid salmonella septicemia and visceral leishmaniosis in a renal transplant patient.Transplantation 2001;71:479-481.
[28]Sabbatini M,Pisani A,Ragosta A,Gallo R,Borrelli F,Cianciaruso B.Visceral leishmaniasis in renal transplant recipients:is it a challenge to the nephrologist?Transplantation 2002;73:299-301.
[29]Maggi P,Gaudiano V,Valente M,Latorraca A,Cavaliere RL,Marroni M,et al.Leishmaniasis in patients with chronic renal failure:a diagnostic and therapeutic challenge for the clinician.J Nephrol 2004;17:296-301.
[30]Boelaert M,Criel B,Leeuwenburg J,Van Damme W,Le Ray D,Van der Stuyft P.Visceral leishmaniasis control:a public health perspective.Trans R Soc Trop Med Hyg 2000;94:465-471.
[31]Alvar J,Molina R,San Andrés M,Tesouro M,Nieto J,Vitutia M,et al.Canine leishmaniasis:clinical,parasitological and entomological followup after chemotherapy.Ann Trop Med Parasitol 1994;88:371-378.
[32]Gavgani AS,Hodjati MH,Mohite H,Davies CR.Effect of insecticideimpregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children:a matched-cluster randomized trial.Lancet 2002;360:374-379.
[33]Guerin PJ,Olliaro P,Sundar S,Boelaert M,Croft SL,Desjeux P,et al.Visceral leishmaniasis:current status of control,diagnosis,and treatment,and a proposed research and development agenda.Lancet Infect Dis 2002;2:494-501.
[34]Ameen M.Cutaneous leishmaniasis:therapeutic strategies and future directions.Expert Opin Pharmacother 2007;8:2689-2699.
[35]Collin S,Davidson R,Ritmeijer K,Keus K,Melaku Y,Kipngetich S,Davies C.Conflict and kala-azar:determinants of adverse outcomes of kala-azar among patients in southern Sudan.Clin Infect Dis 2004;38:612-619.
[36]Croft SL,Sundar S,Fairlamb AH.Drug resistance in leishmaniasis.Clin Microbiol Rev 2006;19:111-126.
[37]Sundar S,More DK,Singh MK,Singh VP,Sharma S,Makharia A,et al.Failure of pentavalent antimony in visceral leishmaniasis in India:report from the center of the Indian epidemic.Clin Infect Dis 2000;31:1104-1107.
[38]Gradoni L,Gramiccia M,Scalone A.Visceral leishmaniasis treatment,Italy.Emerg Infect Dis 2003;9:1617-1620.
[39]Bern C,Adler-Moore J,Berenguer J,Boelaert M,den Boer M,Davidson RN,et al.Liposomal amphotericin B for the treatment of visceral leishmaniasis.Clin Infect Dis 2006;43:917-924.
[40]Pérez-Victoria FJ,Sánchez-Ca?ete MP,Seifert K,Croft SL,Sundar S,Castanys S,et al.Mechanisms of experimental resistance of Leishmania to miltefosine:implications for clinical use.Drug Resist Update 2006;9:26-39.
[41]Thakur CP.Socio-economics of visceral leishmaniasis in Bihar(India).Trans R Soc Trop Med Hyg 2000;94:156-157.
[42]Bryceson A.A policy for leishmaniasis with respect to the prevention and control of drug resistance.Trop Med Int Health 2001;6:928-934.
[43]El Hajj L,Thellier M,Carriere J,Bricaire F,Danis M,Caumes E.Localized cutaneous leishmaniasis imported into Paris:a review of 39cases.Int J Dermatol 2004;43:120-125.
[44]Rosbotham JL,Corbett EL,Grant HR,Hay RJ,Bryceson AD.Imported mucocutaneous leishmaniasis.Clin Exp Dermatol 1996;21:288-290.
[45]Galioto P,Fornaro V.A case of mucocutaneous leishmaniasis.Ear Nose Throat J 2002;81:46-48.
[46]Alcais A,Abel L,David C,Torrez ME,Flandre P,Dedet JP.Risk factors for onset of cutaneous and mucocutaneous leishmaniasis in Bolivia.Am J Trop Med Hyg 1997;57:79-84.
[47]Harms G,Schonian G,Feldmeier H.Leishmaniasis in Germany.Emerg infect Dis 2003;9:872-875.
[48]Naucke TJ,Schmitt C.Is leishmaniasis becoming endemic in Germany?Int J Med Microbiol 2004;37:179-181.
[49]Duprey ZH,Steurer FJ,Rooney JA,Kirchhoff LV,Jackson JE,Rowton ED,et al.Canine visceral leishmaniasis,United States and Canada,2000-2003.Emerg infect Dis 2006;12:440-446.
[50]Desjeux P.The increase in risk factors for leishmaniasis worldwide.Trans R Soc Trop Med Hyg 2001;95:239-243.
[51]Meinecke CK,Schottelius J,Oskam L,Fleischer B.Congenital transmission of visceral leishmaniasis(kala azar)from an asymptomatic mother to her child.Pediatrics 1999;104:65.
[52]Trotz-Williams LA,Trees AJ.Systematic review of the distribution of the major vector-borne parasitic infections in dogs and cats in Europe.Vet Rec 2003;152:97-105.
[53]Mettler M,Grimm F,Naucke TJ,Maasjost C,Deplazes P.Canine leishmaniosis in Central Europe:retrospective survey and serological study of imported and travelling dogs.Berl Münch tier?rztl Wochenschr2005;118:37-44.
[54]Dantas-Torres F,Solano-Gallego L,Baneth G,Ribeiro VM,de PaivaCavalcanti M,Otranto D.Canine leishmaniosis in the Old and New Worlds:unveiled similarities and differences.Trends Parasitol 2012;28:531-538.
[55]Maroli M,Rossi L,Baldelli R,Capelli G,Ferroglio E,Genchi C,et al.The northward spread of leishmaniasis in Italy:evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors.Trop Med Int Health 2008;13:256-264.
[56]Otranto D,Paradies P,de Caprariis D,Stanneck D,Testini G,Grimm F,et al.Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic.Clin Vaccine Immunol2009;16:337-343.
[57]Petersen CA,Barr SC.Canine leishmaniasis in North America:emerging or newly recognized?Vet Clin North Am Small Anim 2009;39:1065-1074.
[58]Naucke TJ,Lorentz S.First report of venereal and vertical transmission of canine leishmaniosis from naturally infected dogs in Germany.Parasit Vectors 2012;5:67.
[59]World Health Organization.Leishmania/HIV co-infection,south-western Europe,1990–1998.WER.1999;74:365-375.
[60]Marty P,Izri A,Ozon C,Haas P,Rosenthal E,Del Giudice P et al.A century of leishmaniasis in Alpes-Maritimes,France.Ann Trop Med Parasitol 2007;101:563-574.
[61]Alvar J,Aparicio P,Aseffa A,Den Boer M,Ca?avate C,Dedet JP,et al.The relationship between leishmaniasis and AIDS:the second 10 years.Clin Microbiol Rev 2008;21:334-359.
[62]Cascio A,Gradoni L,Scarlata F,Gramiccia M,Giordano S,Russo R,et al.Epidemiological surveillance of visceral leishmaniasis in Sicily.Am J Trop Med Hyg 1997;57:75-78.
[63]Mannocci A,La Torre G,Chiaradia G,De Waure C,Mainelli MT,Cernigliaro A,et al.Epidemiology and direct medical costs of human leishmaniasis in Italy.J Prev Med Hyg 2007;48:27-36.
[64]Desjeux P,Alvar J.Leishmania/HIV co-infections:epidemiology in Europe.Ann trop Med Parasitol 2003;97:S3-S15.
[65]Gabutti G,Balestra G,Fkego G,Crovari P.Visceral leishmaniasis in Liguria,Italy.Lancet 1998;351:1136.
[66]Pagliano P,Rossi M,Rescigno C,Altieri S,Coppola MG,Gramiccia M,et al.Mediterranean visceral leishmaniasis in HIV negative adults:a retrospective analysis of 64 consecutive cases(1995-2001).J Antimicrob Chemother 2003;52:264-268.
[67]Russo R,Laguna F,López-Vélez R,Medrano FJ,Rosenthal E,Cacopardo B,et al.Visceral leishmaniasis in those infected with HIV:clinical aspects and other opportunistic infections.Ann Trop Med Parasitol 2003;97:99-105.
[68]Noyes HA,Reyburn H,Bailey W,Smith D.A nested PCR based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan.J Clin Microbiol1998;36:2877-2881.
[69]Malik ANJ,John L,Bryceson ADM,Lockwood DNJ.Changing Pattern of Visceral Leishmaniasis,United Kingdom,1985-2004.Emerg Infect Dis2006;12:1257-1259.
[70]Garrote JI,Gutiérrez MP,Izquierdo RL,Due?as MA,Zarzosa P,Ca?avate C,et al.Seroepidemiologic study of Leishmania infantum infection in Castilla-Leon,Spain.Am J Trop Med Hyg 2004;71:403-6.
[71]Riera C,Fisa R,Udina M,Gállego M,Portus M.Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area(Eivissa,Balearic islands,Spain)by different diagnostic methods.Trans R Soc Trop Med Hyg 2004;98:102-110.
[72]Bates PA.Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies.Int J Parasitol 2007;37:1097-1106.
[73]Franke CR,Staubach C,Ziller M,Schluter H.Trends in the temporal and spatial distribution of visceral and cutaneous leishmaniasis in the state of Bahia Brazil from 1985 to 1999.Trans R Soc Trop Med Hyg 2002;96:236-241.
[74]Ready PD.Leishmaniasis emergence and climate change.In:S de la Roque,editor.Climate change:the impact on the epidemiology and control of animal diseases.Rev Sci Tech Off Int Epiz 2008;27:399-412.
[75]Reithinger R,Canales Espinoza J,Llanos-Cuentas A,Davies CR.Domestic dog ownership:a risk factor for human infection with Leishmania(Viannia)species.Trans R Soc Trop Med Hyg 2003;97:141-145.
[76]Negera E,Gadisa E,Yamuah L,Engers H,Hussein J,Kuru T,et al.Outbreak of cutaneous leishmaniasis in Silti woreda,Ethiopia:risk factor assessment and causative agent identification.Trans R Soc Trop Med Hyg2008;102:883-890.
[77]Pedrosa Fde A,Ximenes RA.Sociodemographic and environmental risk factors for American cutaneous leishmaniasis(ACL)in the State of Alagoas,Brazil.Am J Trop Med Hyg 2009;81:195-201.
[78]Reithinger R,Mohsen M,Leslie T.Risk Factors for Anthroponotic Cutaneous Leishmaniasis at the Household Level in Kabul,Afghanistan.PLoS Negl Trop Dis 2010;4:e639.
[79]Killick-Kendrick R.The biology and control of phlebotomine sand flies.Clin Dermatol 1999;17:279-289.
[80]Kirby MJ,Ameh D,Bottomley C,Green C,Jawara M,Milligan PJ,et al.Effect of two different house screening interventions on exposure to malaria vectors and on anaemia in children in The Gambia:a randomised controlled trial.Lancet 2009;374:998-1009.
[81]Boelaert M,Meheus F,Sanchez A,Singh SP,Vanlerberghe V,Picado A,et al.The poorest of the poor:a poverty appraisal of households affected by visceral leishmaniasis in Bihar,India.Trop Med Int Health 2009;14:639-644.
[82]Bern C,Courtenay O,Alvar J.Of cattle,sandflies and men:a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination.PLoS Negl Trop Dis 2010;4:e599.
[83]Hasker E,Singh SP,Malaviya P,Picado A,Gidwani K,Singh RP,et al.Visceral leishmaniasis in rural bihar,India.Emerg Infect Dis 2012;18:1662-1664.
[84]Pascual Mart?′nez F,Picado A,Roddy P,Palma P.Low castes have poor access to visceral leishmaniasis treatment in Bihar,India.Trop Med Int Health 2012;17:666-673.
[85]Stauch A,Sarkar RR,Picado A,Ostyn B,Sundar S,Rijal S,et al.Visceral leishmaniasis in the Indian subcontinent:modelling epidemiology and control.PLoS Negl Trop Dis 2011;5:e1405.
[86]Barnett PG,Singh SP,Bern C,Hightower AW,Sundar S.Virgin soil:the spread of visceral leishmaniasis into Uttar Pradesh,India.Am J Trop Med Hyg 2005;73:720-725.
[87]Picado A,Ostyn B,Singh SP,Uranw S,Hasker E,Rijal S,et al.Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal.PLoS One 2014;9:e87641.
[88]Saha S,Ramachandran R,Hutin YJF,Gupte MD.Visceral leishmaniasis is preventable in a highly endemic village in West Bengal,India.Trans R Soc Trop Med Hyg 2009;103:737-742.
[89]Yazdanpanah HA,Rostamianpur M.Analysis of spatial distribution of leishmaniasis and its relationship with climatic parameters(Case study:Ilam Province).Bull Env Pharmacol Life Sci 2013;2:80-86.
[90]Mozafari Y,Bakhshizade Koloche F.The Review Relationship between vegetation and the prevalence of skin disease,cutaneous leishmaniasis using GIS in Yazd–ardakan.J Geo Environ Plan 2011;4:186.
[91]Dawit G,Shishay K.Epidemiology,Public Health Impact and Control Methods of the Most Neglected Parasite Diseases in Ethiopia:A Review.World J Med Scien 2014;10:94-102.
[92]Patz JA,Graczyk TK,Geller N,Vittor AY.Effects of environmental change on emerging parasitic diseases.Int J Parasitol 2000;30:1395-1405.
[93]Malone JB,Yilma JM,McC arroll JC,Erko B,Mukaratirwa S,Zhou X.Satellite climatology and the environmental risk of Schistosoma mansoni in Ethiopia and east Africa.Acta Trop 2001;79:59-72.
[94]Brownstein JS,Holford TR,Fish D.A climate-based model predicts the spatial distribution of the lyme disease vector Ixodes scapularis in the United States.Environ Health Perspect 2003;111:1152-1157.
[95]Gebre-Michael T,Malone JB,Balkew M,Ali A,Berhe N,Hailu A,Herzi AA.Mapping the potential distribution of Phlebotomus martini and P.orientalis(Diptera:Psychodidae),vectors of kala-azar in East Africa by use of geographic information systems.Acta Trop 2004;90:73-86.
[96]Brownstein JS,Skelly DK,Holford TR,Fish D.Forest fragmentation predicts local scale heterogeneity of Lyme disease risk.Oecologia 2005;146:469-475.
[97]Silue KD,Raso G,Yapi A,Vounatsou P,Tanner M,N’goran EK,et al.Spatially-explicit risk profiling of Plasmodium falciparum infections at a small scale:a geostatistical modeling approach.Malar J 2008;7:111.
[98]King RJ,Campbell-Lendrum DH,Davies CR.Predicting geographic variation in cutaneous leishmaniasis,Colombia.Emerg Infect Dis 2004;10:598-607.
[99]Feliciangeli MD,Delgado O,Suarez B,Bravo A.Leishmania aand sand flies:proximity to woodland as a risk factor for infection in a rural focus of visceral leishmaniasis in west central Venezuela.Trop Med Int Health2006;11:1785-1791.
[100]Walsh JF,Molyneaux DH,Birley MH.Deforestation:effects on vectorborne disease.Parasitology 1993;106:55-75.
[101]Davies CR,Reithinger R,Campbell-Lendrum D,Feliciangeli D,Borges R,Rodriguez N.The epidemiology and control of leishmaniasis in Andean countries.Cad Saude Publica 2000;16:925-950.
[102]Elnaiem DE,Schorscher J,Bendall A,Obsomer V,Osman ME,Mekkawi AM,et al.Risk mapping of visceral leishmaniasis:the role of local variation in rainfall and altitude on the presence and incidence of kala-azar in eastern Sudan.Am J Trop Med Hyg 2003;6:10-17.
[103]Chaves LF,Pascual M.Climate cycles and forecasts of cutaneous leishmaniasis,a nonstationary vector-borne disease.PLoS Med 2006;3:e295.
[104]Valderrama-Ardila C,Alexander N,Ferro C,Cadena H,Marín D,Holford TR,et al.Environmental Risk Factors for the Incidence of American Cutaneous Leishmaniasis in a Sub-Andean Zone of Colombia(Chaparral,Tolima).Am J Trop Med Hyg 2010;82:243-250.
[105]Kassiri H,Shemshad Kh,Lotfi M,Shemshad M.Relationship Trend Analysis of Cutaneous Leishmaniasis Prevalence and Climatological Variables in Shush County,South-West of Iran(2003-2007).Acad J Entomol 2013;6:79-84.
[106]Moosa-Kazemi SH,Yaghoobi-Ershadir MR,Akhavan AA,Abdoli H,Zahraei-Ramazani AR,Jafari R,et al.Deltamethrin-Impregnated Bed Nets and Curtains in an Anthroponotic Cutaneous leishmaniasis Control Program in Northeastern Iran.Ann Saudi Med 2007;27:6-12.
[107]Bailey MS,Diana NJ.Cutaneous Leishmaniasis.Clinics in Dermatology2007;25:203-211.
[108]Rastogi V,Nirwan PS.Cutaneous Leishmaniasis:an Emerging Infection in a Non-Endemic Area and a Brief Update.Indian J Med Microbiol2007;25:272-275.
[109]Stewart CC,Brieger WR.Community Views on Cutaneous Leishmaniasis in Istalif,Afghanistan:Implications for Treatment and Prevention.Int Q Community Health Educ 2009;29:123-142.
[110]Hotez PJ,Remme JH,Buss P,Alleyne G,Morel C,Breman JG.Combating tropical infectious diseases:report of the Disease Control Priorities in Developing Countries Project.Clin Infect Dis 2004;38:871-878.
[111]Ahluwalia IB,Bern C,Costa C,Akter T,Chowdhury R,Ali M,et al.Visceral leishmaniasis:consequences of a neglected disease in a Bangladeshi community.Am J Trop Med Hyg 2003;69:624-628.
[112]Alvar J,Yactayo S,Bern C.Leishmaniasis and poverty.Trends Parasitol2006;22:552-557.
[113]Rijal S,Koirala S,Van der Stuyft P,Boelaert M.The economic burden of visceral leishmaniasis for households in Nepal.Trans R Soc Trop Med Hyg 2006;100:838-841.
[114]Gafurov IM.Experience in controlling and preventing zoonotic cutaneous leishmaniasis in Uzbekistan.Med Parazitol(Mosk)1999;1:58-59.
[115]Dantas-Torres F,Brandao-Filho SP.Visceral leishmaniasis in Brazil:revisiting paradigms of epidemiology and control.Rev Inst Med Trop Sao Paulo 2006;48:151-156.
[116]Palatnik-de-Sousa CB.Vaccines for leishmaniasis in the fore coming 25years.Vaccine 2008;26:1709-1724.
[117]World Health Organization(WHO).Leishmaniasis:background information.A brief history of the disease.[Online]Available from:www.who.int/leishmaniasis/en/[accssed on 10 May,2016]
[118]Alvar J,Ca?avate C,Gutiérrez-Solar B,Jiménez M,Laguna F,LópezVélez R,et al.Leishmania and human immunodeficiency virus coinfection:the first 10 years.Clin Microbiol Rev 1997;10:298-319.